DRD2 and schizophrenia: We used high-resolution PET, a radioligand with very high affinity, well suited to quantify D2-R availability in low-density extrastriatal brain regions31, and a battery of cognitive tests specifically developed to be sensitive to cognitive impairment in schizophrenia.